Modern Dental Group Announces 2026 Interim Results 
Merdeka Gold Delivers Strong Q2 Production Ramp-Up as Pani Gold Mine Advances Toward Full-year Growth 
Nissin Foods Announces 2026 Interim Results 
The World’s Leading Minds in Biotechnology Will Meet in Riyadh This September 
Overseas Growth Gathers Momentum as CanSinoBIO’s Global Strategy Unlocks New Opportunities Blancco joins AWS ISV Accelerate Program, emphasizing the company’s shared visions around sustainability
New collaboration sees Blancco help AWS customers extend the life of IT assets AUSTIN and…
ThreatQuotient Publishes Research Report: State of Cyber Security Automation Adoption in 2021
Report highlights trends and challenges of automating IT security systems and how CISOs and senior…
DLS Technology places No. 352 on The Globe and Mail’s third-annual ranking of Canada’s Top Growing Companies
OTTAWA, Sept. 28, 2021 (GLOBE NEWSWIRE) — DLS Technology is pleased to announce it placed…
Banyan Security Democratizes Zero Trust Access with Team Edition
The Industry’s Most Secure and Productivity-Enhancing Remote Access Solution Now Available for Software Development Teams…
Philogen Provides Corporate Update
Philogen Provides Corporate Update Nidlegy™ and Fibromun on track with planned timelines in pivotal clinical…
Linneo Health appoints Don Bellamy as Chief Executive Officer
Linneo Health appoints Don Bellamy as Chief Executive Officer Experienced executive bringing over 30 years’…
Immunicum AB (publ) Announces Outcome of Subscription in Incentive Program LTI 2021/2024
Press Release 29 September 2021 Immunicum AB (publ) Announces Outcome of Subscription in Incentive Program…
Biophytis to Present Full Results From the SARA-INT Phase 2b Trial of Sarconeos (BIO101) in Sarcopenia at the 11th Annual International Conference on Frailty and Sarcopenia Research (ICFSR) September 29 – October 2, 2021
PARIS and CAMBRIDGE, Mass., Sept. 29, 2021 (GLOBE NEWSWIRE) — Biophytis SA (NasdaqCM: BPTS, Euronext…
Nicox’s NCX 470 Shows Retinal Cell Protection in a Nonclinical Model
Press Release Nicox’s NCX 470 Shows Retinal Cell Protection in a Nonclinical Model September 29,…
Addex to Present at the Cantor Global Healthcare 2021 Conference
Geneva, Switzerland, September 29, 2021 – Addex Therapeutics (SIX: ADXN), a clinical-stage pharmaceutical company pioneering allosteric…
Addex Therapeutics Initiates Phase 2 Clinical Study with Dipraglurant in Blepharospasm
Type of dystonia characterized by involuntary spasms of the eyelid muscles can lead to substantial…
Acacia Pharma Announces Submission and Validation of Marketing Authorization Application for BARHEMSYS® (amisulpride injection) in Major European Markets
This announcement contains inside information for the purposes of Article 7 of the Market Abuse…
Celldex Presents Positive Data on Symptom Control and Quality of Life Measurements that Further Support CDX-0159 Clinical Benefit in Phase 1b Study in Chronic Inducible Urticaria at EADV 2021
– Rapid and sustained improvement in urticaria control after single dose of CDX-0159 –– Greatly…
HUTCHMED Highlights Oral Presentations at 2021 Chinese Society of Clinical Oncology Annual Meeting
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Sept. 28, 2021 (GLOBE NEWSWIRE) —…
HUTCHMED Announces Closing of Divestment of Non-Core OTC Joint Venture
HONG KONG and FLORHAM PARK, N.J., Sept. 29, 2021 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited…
PharmaTher Announces Closing of CAD$10 Million Private Placement with Institutional Investors
TORONTO, Sept. 28, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (CSE:…
Iovance Biotherapeutics Celebrates Grand Opening of Iovance Cell Therapy Center (iCTC) in the Philadelphia Navy Yard
Ribbon Cutting to be Led by Patient Advocacy Organizations, Caregivers, and Key Stakeholders Largest and…
Genocea to Present at Upcoming Conferences
CAMBRIDGE, Mass., Sept. 28, 2021 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical…
Vaxcyte to Present at Guggenheim 2nd Annual Vaccine and Infectious Disease Conference
FOSTER CITY, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation…
Terns Appoints Veteran Biopharmaceutical Executive Ann E. Taylor, M.D. to Board of Directors
FOSTER CITY, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the…